Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Sharing information with shareholders, Sun Pharmaceutical Industries
Managing Director Dilip Shanghvi said the company's strategy of
developing the specialty business as an additional growth engine has
started delivering results, with a gradual ramp up in specialty
revenues.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-bullish-on-specialty-biz-looks-to-expand-the-segment-to-new-geographies/articleshow/78344062.cms

Comments

Popular posts from this blog

Sunday Worship Service

India may soon line up for Putin’s once-scorned vaccine - now a favorite in pandemic fight